Outcomes of Asian Women Treated With Grisotti Flap Reconstruction for Centrally Located Breast Cancers: 5-Years Single Institutional Experience. Issue 2 (August 2021)

• Record Type: Journal Article
• Authors: Teh, Mei-Sze; Teoh, Li-Ying; Jamaris, Suniza; Lai, Lee-Lee; See, Mee-Hoong
• Is Part Of: Annals of plastic surgery. Volume 87:Issue 2(2021)
• Publication Date: 2021-08
• Subjects: breast cancer -- centrally located breast cancer -- Grisotti flap -- oncoplastic breast surgery -- oncology -- retroareolar cancer; Surgery, Plastic -- Periodicals; 617.95205
• DOI: 10.1097/SAP.0000000000002631
• Languages: English
• ISSNs: 0148-7043

Abstract

Abstract : Introduction: Breast conserving surgeries were previously contraindicated for central breast cancers because of poor cosmetic outcomes of central mastectomy without oncoplastic surgery. Grisotti flap is a breast-conserving surgery incorporating oncoplastic surgery technique for centrally located breast cancers. We present our experience and outcome from Breast Surgery Unit, University Malaya Medical Center. Materials and Methods: A prospective analysis of 15 patients with central retroareolar breast cancer operated from 2012 to 2018 in University Malaya Medical Center. We assessed postoperative complications, margins, locoregional recurrence, and survival outcome. All patients received postoperative radiotherapy. Patients were followed-up 1 week, 1 month, 3 monthly for 1 year and 6 monthly for 5 years. Results: Mean age of patients is 62 years. Mean follow-up is 51 months (15–84 months). All tumors were less than 5 cm (1–2.5 cm). Majority of the patients are stage 1 (6 patients/40%) and stage 2 (8 patients/ 53.3%). 2 patients had surgical site infection resolved with antibiotics. One patient had hematoma. None require reoperation. Tumor margins were clear in all patients. No locoregional recurrence. Overall survival is 100%. All are satisfied with their cosmetic outcomes. Conclusions: Grisotti flap is a volume displacement technique, which provides satisfactory cosmetic outcome for centrally located breast cancer. This evolutionary thinking leads us to changes in existing techniques with the purpose of achieving oncological safety while reaching for better esthetic results. Our 5 years' experience in Asian population showed that this technique is oncologically safe with good cosmetic outcomes and could be used selectively. It provides a good alternative in patients who are otherwise subjected for mastectomy. This relatively simple technique is a worthwhile endeavor and should be offered when feasible.